LANDSCAPE OF KRAS G12C MUTATIONS IN GENITOURINARY MALIGNANCIES

被引：0
|
作者：
Rebecca, Sager A.
Michael, Basin F.
Hanan, Goldberg
Jeffrey, Ross S.
Gennady, Bratslavsky
Joseph, Jacob M.
Petros, Grivas
Andrea, Necchi
机构：
[1] SUNY Upstate Med Univ, Syracuse, NY 13210 USA
[2] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
[3] Univ Vita Salute San Raffaele, Milan, Italy
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2024年 / 42卷
关键词：
D O I：
10.1016/j.urolonc.2024.01.198
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
161
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [21] Covalent Guanosine Mimetic Inhibitors of G12C KRAS
    Xiong, Yuan
    Lu, Jia
    Hunter, John
    Li, Lianbo
    Scott, David
    Choi, Hwan Geun
    Lim, Sang Min
    Manandhar, Anuj
    Gondi, Sudershan
    Sim, Taebo
    Westover, Kenneth D.
    Gray, Nathanael S.
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (01): : 61 - 66
  • [22] G12V and G12C mutations in the gene KRAS are associated with a poorer prognosis in primary colorectal cancer
    Tamuro Hayama
    Yojiro Hashiguchi
    Koichi Okamoto
    Yuka Okada
    Kohei Ono
    Ryu Shimada
    Tsuyoshi Ozawa
    Tetsutaka Toyoda
    Takeshi Tsuchiya
    Hisae Iinuma
    Keijiro Nozawa
    Keiji Matsuda
    International Journal of Colorectal Disease, 2019, 34 : 1491 - 1496
  • [23] Two new agents target KRAS G12C
    Diana Romero
    Nature Reviews Clinical Oncology, 2020, 17 (1) : 6 - 6
  • [24] Immunogenomics of Clinical Resistance to KRAS G12C Inhibition
    Woodcock, M.
    Tsai, Y. S.
    Azam, S. H.
    Thorne, L. B.
    Kanchi, K. L.
    Parker, J. S.
    Vincent, B. G.
    Pecot, C. V.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S599 - S600
  • [25] Two new agents target KRAS G12C
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (01) : 6 - 6
  • [26] Targeting KRAS G12C mutation in lung adenocarcinoma
    Rohatgi, Anjali
    Govindan, Ramaswamy
    LUNG CANCER, 2022, 165 : 28 - 33
  • [27] G12V and G12C mutations in the gene KRAS are associated with a poorer prognosis in primary colorectal cancer
    Hayama, Tamuro
    Hashiguchi, Yojiro
    Okamoto, Koichi
    Okada, Yuka
    Ono, Kohei
    Shimada, Ryu
    Ozawa, Tsuyoshi
    Toyoda, Tetsutaka
    Tsuchiya, Takeshi
    Iinuma, Hisae
    Nozawa, Keijiro
    Matsuda, Keiji
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2019, 34 (08) : 1491 - 1496
  • [28] KRAS G12C inhibition and innate immune targeting
    Tani, Tetsuo
    Kitajima, Shunsuke
    Conway, Ella B.
    Knelson, Erik H.
    Barbie, David A.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (03) : 167 - 174
  • [29] Overcoming adaptive resistance to KRAS G12C inhibitors
    Adachi, Yuta
    Niitsu, Hiroaki
    Yamaguchi, Rui
    Ebi, Hiromichi
    CANCER SCIENCE, 2024, 115 : 110 - 110
  • [30] Characterizing the clinico-genomic landscape and outcomes of KRAS G12C mutated pancreas cancer
    Keane, F.
    Park, W.
    Varghese, A.
    Balogun, F.
    Yu, K.
    El Dika, I.
    Khalil, D.
    Kelsen, D. P.
    Reidy-Lagunes, D.
    Ku, G. Y.
    Raj, N.
    Chou, J. F.
    Capanu, M.
    Schultz, N.
    Yaeger, R.
    O'Reilly, E.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1140 - S1140
12345